Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 2c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of ($0.01), $0.02 worse than the analyst estimate of $0.01.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Sphere Entertainment (SPHR) Reiterated at Market Outperform by Citizens: Global Expansion Apace
• Jefferies Reinstates Booz Allen Hamilton (BAH) at Hold